Taysha Gene Therapies, Inc. TSHA

Updated: 17 Jun 2026

NASDAQ | Biotech | Gene therapy for CNS diseases

No signal published yet

We already track Taysha Gene Therapies and collect the news. No signal is published yet — follow the company free and we will email you when that changes, or run a quick check now.

Follow Taysha Gene Therapies free Follow free

Email when we publish a signal or something material happens · Sunday weekly brief

No card · No time limit on free tier · Upgrade when you need more

Free
No email, no account, no signup.
Exchange
NASDAQ
Type
Biotech
Sector
Gene therapy for CNS diseases
We're already tracking Taysha Gene Therapies, Inc. — here are the latest events we've registered

Recent News

  • In June 2026, the company reported positive early results from the REVEAL Phase 1/2 trial of TSHA-102, demonstrating a high responder rate and durable functional improvements in patients with Rett syndrome. Taysha also reaffirmed its alignment with the FDA on a potential BLA submission pathway based on interim pivotal trial data.

What Firelda Watch includes for Taysha Gene Therapies, Inc.

Add the company to your watchlist and get all of this automatically.

  • Free: 3 companies on your watchlist
  • Change history and monitoring for every company you follow
  • Sunday weekly brief — a short weekly roundup
  • Watch/Ultra: same-day email when something material happens
Want to see what a finished analysis looks like?
View a sample analysis
This is a real Firelda analysis. Your analysis of Taysha Gene Therapies, Inc. will be delivered in the same format.

Sample analyses in the same sector

Sample full analysis — same format your watchlist gets

Bioarctic
BIOA B
BUY
Swedish Orphan Biovitrum AB (publ)
SOBI
HOLD
Moderna, Inc.
MRNA
HOLD
AstraZeneca PLC
AZN
HOLD
Calliditas Therapeutics
CALT
NEUTRAL

Biotech

More companies in this sector

Want to follow Taysha Gene Therapies, Inc.? Create a free account — 3 companies, change history, weekly brief, and email when the picture changes.

Follow Taysha Gene Therapies free Follow free

Email when we publish a signal or something material happens · Sunday weekly brief

No card · No time limit on free tier · Upgrade when you need more

Taysha Gene Therapies, Inc. TSHA
Taysha Gene Therapies — follow and we'll monitor it
Follow Taysha Gene Therapies free Follow free
Firelda provides general information and analysis, not personal investment advice. Content does not consider your financial situation or goals. Investments can rise and fall in value. Always do your own research.